EUVIMEDEUVIMED entdecken
Crossref

Evaluation Of Drug-Induced Hepatotoxicity Using In Vitro And In Vivo Models

Pratiksha Vyavahare, Kranti Akhare, Gayatri Jadhao, Arti Mapari, Vinayak Pitale, Gayatri Khanderao, Mohan Tale, Nilesh Sawadadkar, Nandu Kayande

International Journal of Drug Delivery Technology · 18.05.2026 · 16 (28s)

DOI: 10.25258/ijddt.16.28s.78 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 18.05.2026. Verfasst von Pratiksha Vyavahare und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug-induced hepatotoxicity remains a formidable challenge in pharmaceutical development, accounting for a significant proportion of clinical trial failures and post-marketing withdrawals. This research provides a comprehensive evaluation of current methodologies used to assess liver injury, focusing on the comparative efficacy of traditional in vivo models and emerging in vitro platforms. Historically, preclinical safety has relied heavily on animal models; however, interspecies differences in drug metabolism and disposition often lead to a poor correlation with human clinical outcomes, with studies indicating that animal models may predict only approximately 50% of human hepatotoxicity events. To address these limitations, this study investigates the predictive capacity of various in vitro systems, including primary human hepatocytes, immortalized cell lines, and advanced three-dimensional (3d) organoid cultures. Our analysis demonstrates that while 2d cell cultures provide high-throughput screening capabilities, 3d models more accurately replicate the complex microenvironment and metabolic functionality of the human liver, thereby enhancing the detection of idiosyncratic hepatotoxicity. Furthermore, the integration of toxicogenomics and machine learning algorithms into these models allows for the identification of early biomarkers and mechanistic pathways associated with cellular stress. Despite the advancements in in vitro technologies, in vivo models remain indispensable for characterizing systemic physiological responses and chronic toxicity profiles. This paper concludes that a synergistic approach, combining human-relevant in vitro assays with refined in vivo studies, is essential for improving the accuracy of preclinical risk assessments. Such a dual-model strategy significantly reduces development costs and ensures greater patient safety by identifying potential hepatotoxins prior to clinical exposure.

Zitieren

APA

Vyavahare, P., Akhare, K., Jadhao, G., Mapari, A., Pitale, V., Khanderao, G., Tale, M., Sawadadkar, N., & Kayande, N. (2026). Evaluation Of Drug-Induced Hepatotoxicity Using In Vitro And In Vivo Models. International Journal of Drug Delivery Technology, 16(28s). https://doi.org/10.25258/ijddt.16.28s.78

Vancouver

Vyavahare P, Akhare K, Jadhao G, Mapari A, Pitale V, Khanderao G, et al. Evaluation Of Drug-Induced Hepatotoxicity Using In Vitro And In Vivo Models. International Journal of Drug Delivery Technology. 2026;16(28s). doi:10.25258/ijddt.16.28s.78

BibTeX
@article{Vyavahare2026,
  author = {Vyavahare, Pratiksha and Akhare, Kranti and Jadhao, Gayatri and Mapari, Arti and Pitale, Vinayak and Khanderao, Gayatri and Tale, Mohan and Sawadadkar, Nilesh and Kayande, Nandu},
  title = {Evaluation Of Drug-Induced Hepatotoxicity Using In Vitro And In Vivo Models},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {28s},
  doi = {10.25258/ijddt.16.28s.78}
}
Kostenlos starten →